The company’s growth is fueled by a strategy that prioritizes surgeon independence, allowing clinicians to utilize OrthAlign’s guidance systems regardless of their preferred implant brand. This flexibility has proven critical as procedures migrate away from traditional hospital settings toward outpatient ambulatory surgery centers, where cost-efficiency and procedural speed are paramount.

Chairman and CEO Eric Timko attributed the achievement to the collective trust of the global surgical community and the versatility of the technology across primary and revision arthroplasty. With the company now setting its sights on the one-million-procedure mark, the focus remains on expanding its footprint in international markets and deepening its integration into modern clinical workflows. By maintaining an open-platform approach, OrthAlign continues to position itself as a key supplier for surgeons seeking precision without the constraints of proprietary hardware ecosystems.